RMTG (Regenerative Medical Technology Group) PS Ratio: 0.07 (As of Jul. 11, 2026) — 83% Below Median


What is Regenerative Medical Technology Group PS Ratio?

Regenerative Medical Technology Group RMTG +3.75% PS Ratio is 0.07 as of Jul. 11, 2026, which is 83% below its 10-year median of 0.42. The stock has 4 warning signs investors should review. Among 930 Biotechnology companies, Regenerative Medical Technology Group ranks better than 99.25% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Regenerative Medical Technology Group's share price is $0.03683. Regenerative Medical Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.50. Hence, Regenerative Medical Technology Group's PS Ratio for today is 0.07.

Good Sign:

Regenerative Medical Technology Group Inc stock PS Ratio (=0.04) is close to 10-year low of 0.04.

The historical rank and industry rank for Regenerative Medical Technology Group's PS Ratio or its related term are showing as below:

RMTG' s PS Ratio Range Over the Past 10 Years
Min: 0.04   Med: 0.42   Max: 95
Current: 0.07

During the past 9 years, Regenerative Medical Technology Group's highest PS Ratio was 95.00. The lowest was 0.04. And the median was 0.42.

RMTG's PS Ratio is ranked better than
99.25% of 930 companies
in the Biotechnology industry
Industry Median: 9.515 vs RMTG: 0.07

Regenerative Medical Technology Group's Revenue per Sharefor the three months ended in Mar. 2026 was $0.20. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.50.

Warning Sign:

Regenerative Medical Technology Group Inc revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Regenerative Medical Technology Group was 33.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 47.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 122.30% per year.

During the past 9 years, Regenerative Medical Technology Group's highest 3-Year average Revenue per Share Growth Rate was 218.60% per year. The lowest was -9.10% per year. And the median was 76.50% per year.

Back to Basics: PS Ratio

Regenerative Medical Technology Group  (OTCPK:RMTG) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.

Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.

Regenerative Medical Technology Group PS Ratio Related Terms

Regenerative Medical Technology Group PS Ratio Historical Data

* Premium members only.

The historical data trend for Regenerative Medical Technology Group's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerative Medical Technology Group PS Ratio Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
Get a 7-Day Free Trial Premium Member Only 7.11 0.15 0.04 0.09 0.12

Regenerative Medical Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.11 0.16 0.12 0.06

RMTG vs PTIX, CERO, EMMA: PS Ratio Comparison

For the Biotechnology subindustry, Regenerative Medical Technology Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's PS Ratio falls into.


Regenerative Medical Technology Group PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Regenerative Medical Technology Group's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.03683/0.495
=0.07

Regenerative Medical Technology Group's Share Price of today is $0.03683.
Regenerative Medical Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.50.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 0.07 mean?
Regenerative Medical Technology Group (RMTG) has a PS Ratio of 0.07 as of Jul. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Regenerative Medical Technology Group and its competitors. This is 83% below median its historical median of 0.42. Over the past decade, Regenerative Medical Technology Group's PS Ratio has ranged from 0.04 to 95.00. According to the industry distribution chart, Regenerative Medical Technology Group ranks #7 out of 930 companies in the Biotechnology industry, placing it in the top 0.8%.
Is Regenerative Medical Technology Group's PS Ratio too high?
Regenerative Medical Technology Group's current PS Ratio of 0.07 is 83% below median its 10-year median of 0.42. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 95.00. The Biotechnology industry median PS Ratio is 9.52. Regenerative Medical Technology Group's value of 0.07 is 99.3% below this industry median. Based on the distribution chart, Regenerative Medical Technology Group ranks #7 out of 930 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Regenerative Medical Technology Group's PS Ratio compare to PTIX and CERO?
According to the Biotechnology industry distribution chart, Regenerative Medical Technology Group ranks #7 out of 930 companies for PS Ratio. This places Regenerative Medical Technology Group in the top 1% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.52. Regenerative Medical Technology Group's value of 0.07 is 99.3% below this benchmark. Historically, Regenerative Medical Technology Group's own PS Ratio has ranged from 0.04 to 95.00 over the past decade. While the company's 10-year median is 0.42 vs. the industry median of 9.52, Regenerative Medical Technology Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.52, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Regenerative Medical Technology Group's current PS Ratio of 0.07 is 99.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Regenerative Medical Technology Group and its competitors. For the Biotechnology industry, the median PS Ratio is 9.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regenerative Medical Technology Group's current PS Ratio is 0.07, which is 83% below median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Possible Value Trap. The stock's GF Value™ is $0.06, compared to a current price of $0.04 — trading 38.6% below its estimated fair value. The current PS Ratio is 0.07, which is 83% below median its 10-year median of 0.42 and 99.3% below the Biotechnology industry median of 9.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current PS Ratio is 0.07 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.